Customizable DNA Labels Guide Drug Carriers to Cancer Cells, Carnegie Mellon Study Shows

Researchers at Carnegie Mellon University have harnessed natural cell-to-cell communication to create customizable drug carriers that can deliver treatments directly to cancer cells. By attaching DNA labels to tiny packages that cells naturally send to one another, the team developed a simple, low-cost method to selectively guide these carriers to specific targets, such as tumors. This approach could improve the effectiveness of cancer therapies while reducing harmful side effects on healthy tissues. The technology leverages the body's own transport system, making it potentially more compatible and less toxic than synthetic alternatives. The findings highlight a promising step toward precision medicine, where drugs reach only the intended cells. If successful in further trials, this method could transform how cancer and other diseases are treated, offering a more targeted and patient-friendly approach.